May 14 2024Johns Hopkins Medicine The team says this is a crucial step forward in understanding biological mechanisms behind lupus, and may also lead to shifts in how clinicians treat patients with the condition.
He says this research began with questions about why certain lupus treatments were ineffective for some patients. "We have seen instances where the patient surprisingly didn't improve -; we wondered if certain interferon groups were involved." Researchers were able to use these findings to also make several associations between these interferon combinations and lupus symptoms. In those with elevated interferon I, lupus was mainly associated with symptoms affecting the skin, such as rashes or sores. Participants with elevated levels of interferon I, II and III exhibited the most severe presentations of lupus, often with significant damage to organ systems, such as the kidneys.
Eduardo Gómez-Bañuelos, M.D., Ph.D., rheumatologist, assistant professor of medicine, Johns Hopkins University School of Medicine and study's first and additional corresponding author
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
UK medicine shortages made worse by Brexit, new report findsA NEW report has revealed that medicine shortages across the UK are becoming “the new normal” and are being made worse by Brexit.
Source: SunScotNational - 🏆 49. / 63 Read more »
Source: medical_xpress - 🏆 101. / 51 Read more »
Source: medical_xpress - 🏆 101. / 51 Read more »
Source: medical_xpress - 🏆 101. / 51 Read more »
Source: medical_xpress - 🏆 101. / 51 Read more »